Daniel C. Sloan

Associate

New York + 1.212.326.3639

Daniel Sloan practices intellectual property law and has experience in drafting pleadings, discovery, motions, and trial preparation. Daniel also has experience as part of a Hatch-Waxman trial team representing a brand name pharmaceutical company.

Daniel maintains an active pro bono practice, assisting with the Firm's Border Project, Kids in Need of Defense (KIND), and HER Justice cases. In addition to providing general assistance to asylum seekers fleeing violence in their home countries, Daniel was part of a trial team for a client requesting relief under the Convention Against Torture.

Daniel is active on the PTAB (Patent Trial and Appeal Board) Bar Association's communication committee, a regular contributor to the Firm's PTAB Litigation Blog, and a member of the New York Intellectual Property Association. He is a former member of the Sam A. Crow Inn of Court.

Experience

  • Purdue Pharma asserts patent infringement claims under Hatch-Waxman Act related to OxyContin® against Accord HealthcareJones Day represents plaintiffs Purdue Pharma L.P. and Purdue Pharmaceuticals L.P. ("Purdue") in a patent litigation under the Hatch-Waxman Act in the District of Delaware.
  • Purdue Pharma asserts patent infringement claims under Hatch-Waxman Act related to extended-release oxycodone analgesic productsJones Day represents plaintiffs Purdue Pharma L.P., Purdue Pharmaceuticals L.P. and Rhodes Technologies in a Hatch-Waxman pharmaceutical patent litigation in the District of New Jersey.